Frontiers in Synaptic Neuroscience

Papers
(The TQCC of Frontiers in Synaptic Neuroscience is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Dendritic Spine Plasticity: Function and Mechanisms115
Dendritic Spines Shape Analysis—Classification or Clusterization? Perspective80
Semaphorins in Adult Nervous System Plasticity and Disease53
Impact of Perineuronal Nets on Electrophysiology of Parvalbumin Interneurons, Principal Neurons, and Brain Oscillations: A Review53
The Role of Rac GTPase in Dendritic Spine Morphogenesis and Memory34
Bidirectional Dysregulation of AMPA Receptor-Mediated Synaptic Transmission and Plasticity in Brain Disorders32
Neuroligins and Neurodevelopmental Disorders: X-Linked Genetics30
Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function – Implications for Potential Therapies30
The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome28
The Synapse Diversity Dilemma: Molecular Heterogeneity Confounds Studies of Synapse Function28
Psychedelics as a Treatment for Alzheimer’s Disease Dementia27
A Synaptic Framework for the Persistence of Memory Engrams25
Procedures for Culturing and Genetically Manipulating Murine Hippocampal Postnatal Neurons25
The Good, the Bad and the Unknown Aspects of Ghrelin in Stress Coping and Stress-Related Psychiatric Disorders25
Dopamine in Fear Extinction24
Multiple Roles of Actin in Exo- and Endocytosis24
Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease23
SynapsEM: Computer-Assisted Synapse Morphometry22
Voltage-Gated Ca2+ Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease?22
Taurine Promotes Neurite Outgrowth and Synapse Development of Both Vertebrate and Invertebrate Central Neurons21
The Non-receptor Tyrosine Kinase Pyk2 in Brain Function and Neurological and Psychiatric Diseases21
The Synaptic Extracellular Matrix: Long-Lived, Stable, and Still Remarkably Dynamic20
Calcium signaling in astrocytes and gliotransmitter release20
The Yin and Yang of GABAergic and Glutamatergic Synaptic Plasticity: Opposites in Balance by Crosstalking Mechanisms20
From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein20
The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2* and α3β4* Receptors20
The Decade of Super-Resolution Microscopy of the Presynapse20
Nano-Organization at the Synapse: Segregation of Distinct Forms of Neurotransmission20
Maturation of Heterogeneity in Afferent Synapse Ultrastructure in the Mouse Cochlea19
The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene18
Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: An historical perspective17
The Shaping of AMPA Receptor Surface Distribution by Neuronal Activity17
Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies16
Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage16
Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson’s Disease16
GluN2D NMDA Receptors Gate Fear Extinction Learning and Interneuron Plasticity15
Neuronal Glycoprotein M6a: An Emerging Molecule in Chemical Synapse Formation and Dysfunction15
Microglia Heterogeneity in Alzheimer’s Disease: Insights From Single-Cell Technologies15
Dorsal-Ventral Differences in Modulation of Synaptic Transmission in the Hippocampus14
Parvalbumin Interneurons and Perineuronal Nets in the Hippocampus and Retrosplenial Cortex of Adult Male Mice After Early Social Isolation Stress and Perinatal NMDA Receptor Antagonist Treatment14
Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer’s and Parkinson’s diseases14
The Subcortical-Allocortical- Neocortical continuum for the Emergence and Morphological Heterogeneity of Pyramidal Neurons in the Human Brain14
Poly I:C Activated Microglia Disrupt Perineuronal Nets and Modulate Synaptic Balance in Primary Hippocampal Neurons in vitro14
Room for Two: The Synaptophysin/Synaptobrevin Complex14
Calcium Sensors STIM1 and STIM2 Regulate Different Calcium Functions in Cultured Hippocampal Neurons13
Ocular Hypertension Drives Remodeling of AMPA Receptors in Select Populations of Retinal Ganglion Cells13
Multi-Electrode Array Analysis Identifies Complex Dopamine Responses and Glucose Sensing Properties of Substantia Nigra Neurons in Mouse Brain Slices13
cAMP-Dependent Synaptic Plasticity at the Hippocampal Mossy Fiber Terminal12
Targeting prefrontal cortex GABAergic microcircuits for the treatment of alcohol use disorder12
Dendritic and Spine Heterogeneity of von Economo Neurons in the Human Cingulate Cortex12
GRIN2B-related neurodevelopmental disorder: current understanding of pathophysiological mechanisms12
Autaptic Cultures: Methods and Applications11
Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum11
The Requirement of the C-Terminal Domain of GluA1 in Different Forms of Long-Term Potentiation in the Hippocampus Is Age-Dependent11
Cell-Type-Specific Adaptions in Striatal Medium-Sized Spiny Neurons and Their Roles in Behavioral Responses to Drugs of Abuse11
Molecular mechanisms of synaptogenesis11
Synaptic Vesicle Recycling and the Endolysosomal System: A Reappraisal of Form and Function10
Transient Enhanced GluA2 Expression in Young Hippocampal Neurons of a Fragile X Mouse Model10
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction10
Organization of Presynaptic Autophagy-Related Processes10
Two Distinct Populations of α1α6-Containing GABAA-Receptors in Rat Cerebellum10
Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice10
0.027235984802246